Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination

NCT01650389 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

248

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
HIV

Interventions

BIOLOGICAL: MVA85A
BIOLOGICAL: Candin
BIOLOGICAL: BCG Vaccine SSI

Sponsor

Mark Hatherill

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]